MODAG: positive phase 1 results of potential new Parkinson’s drug
Supported by Cure Parkinson’s, German Biotech company MODAG have announced positive results from their phase 1 clinical trial of Anle138b for Parkinson’s.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
